Dermatology Times

🗓💊 THE RX RECAP: This week, we feature top articles from our sister publications on first-in-class antibiotics, AI-enabled software for chest X-rays, and more. 🖇 Read more: https://lnkd.in/eJXJqY_g

🌟🗓 TOP 5 ROUNDUP: Explore the top 5 articles from Dermatology Times from the past week, including insights on clinical trials, CBD products, upcoming conferences, and more. 🖇 Read more: https://lnkd.in/gNDPDnXP

🌟 Welcome to this week's edition of Dermatology Times' LinkedIn newsletter! As March wraps up, we're reflecting on a month rich with advancements in dermatology. Review insights from the month in this Skin-Sights: Month in Review edition. ⬇️ 👥📲 Join our community of more than 13,200 (and counting!) dermatology and industry professionals receiving curated skin news every week by subscribing to our newsletter today.

Today is the last day to save on early bird pricing for the Revolutionizing Atopic Dermatitis (RAD) Conference, happening June 6-7 in Nashville, TN! Earn CME credits over two full days while exploring groundbreaking concepts in atopic dermatitis. Claim your discount now: https://bit.ly/4id1vXK #AtopicDermatitis #gotoper #Dermatology

🗓 WEEKLY ROUNDUP: Review our recap of news from last week, including the use of CBD products in dermatology, Journey Medical Corporation's launch of Emrosi for rosacea, the psychological impact of melanoma, and more. 🖇 Read more: https://lnkd.in/gqbvWGYP

As March comes to a close, Dermatology Times is recognizing the strides and contributions of female leaders in our field 💜 Check out our full recap of articles to celebrate Women’s History Month 2025! ⬇️ 🖇 Read more: https://lnkd.in/g4AecNMe

🔑 🔓 ✨ SPECIAL REPORT: Get an exclusive and comprehensive look at the latest FDA approvals and pipeline developments in dermatology from the first quarter of 2025. 🖇 Read more: https://lnkd.in/gmqPVaQq

📰 FROM OUR PUBLICATION: The March issue of  Dermatology Times includes a collection of thought-provoking articles and topics ranging from the potential role of CBD in therapeutic dermatology to a discussion on the challenges of pigmentary disorders in women across the Fitzpatrick skin spectrum. Don’t miss a moment of Dermatology Times by signing up for our eNewsletters and subscribing to receive the free print issue and supplement each month! https://lnkd.in/gagQjzsJ

📚 STUDY FINDINGS: A study on topical cannabinoid therapy for atopic dermatitis showed significant improvements in hydration, skin barrier function, and erythema after 8 weeks. Cannabidiol (CBD) and cannabigerol (CBG) helped reduce symptoms, but further long-term research is needed. 🖇 Read more: https://lnkd.in/gawNrxBy

🔑✨ INTERVIEW INTERSECTION: Explore Dermatology Times' recap of our top expert interviews from the month of March, featuring insights on aesthetic innovations, clinical developments, and more. 🗓 ⬇️ https://lnkd.in/gwiAhP-R